TA Levin Large Cap Value VP
|Security Description||% of Total Net Assets|
|Bio-Rad Laboratories, Inc., Class A||5.76%|
|American International Group, Inc.||5.32%|
|JPMorgan Chase & Co.||4.81%|
|Bank of America Corp.||4.61%|
|Occidental Petroleum Corp.||4.25%|
|General Motors Co.||3.63%|
|CenterPoint Energy, Inc.||3.62%|
|Keurig Dr. Pepper, Inc.||3.33%|
|TreeHouse Foods, Inc.||3.31%|
|Nokia OYJ, ADR||3.08%|
|Kraft Heinz Co.||2.97%|
|CommScope Holding Co., Inc.||2.63%|
|Lincoln National Corp.||2.51%|
|Exxon Mobil Corp.||1.96%|
|Lowe's Cos., Inc.||1.67%|
|Goodyear Tire & Rubber Co.||1.06%|
|Net Other Assets (Liabilities)||4.57%|
Unlike the fund’s regulatory filings, the portfolio data and its presentation in this document are not required to conform to Generally Accepted Accounting Principles (GAAP) and Securities and Exchange Commission (SEC) presentation requirements. Therefore, it differs from that in the complete statement of investments in the annual and semiannual report to shareholders filed with the SEC on Form N-CSR, and the complete statement of investments provided in the first and third quarter SEC Form N-Q filings for each fiscal year.
Transamerica Series Trust portfolios are only available through the purchase of a variable life insurance policy or variable annuity contract.
No part of this material may be reproduced in any form, or referred to in any publication, without express written permission.